{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:20:06Z","timestamp":1784704806061,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.06.082","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T08:21:47Z","timestamp":1562746907000},"page":"A127-A131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward"],"prefix":"10.1016","volume":"38","author":[{"given":"Md Taufiqul","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.06.082_b0005","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.06.082_b0010","series-title":"Cholera","first-page":"1","article-title":"History of cholera","author":"Barua","year":"1992"},{"issue":"19","key":"10.1016\/j.vaccine.2019.06.082_b0015","doi-asserted-by":"crossref","DOI":"10.1029\/2009GL039312","article-title":"Dual peak cholera transmission in Bengal Delta: a hydroclimatological explanation","volume":"36","author":"Akanda","year":"2009","journal-title":"Geophys Res Lett"},{"key":"10.1016\/j.vaccine.2019.06.082_b0020","series-title":"Cholera outbreak","first-page":"87","article-title":"Cholera outbreaks in South-East Asia","author":"Bharati","year":"2014"},{"key":"10.1016\/j.vaccine.2019.06.082_b0025","series-title":"Cholera in India: an analysis of reports, 1997\u20132006","first-page":"185","author":"Kanungo","year":"2010"},{"key":"10.1016\/j.vaccine.2019.06.082_b0030","unstructured":"WHA64, R., 15. Cholera: mechanism for control and prevention. Sixty-fourth World Health Assembly, Geneva, 16, 2011. 1."},{"key":"10.1016\/j.vaccine.2019.06.082_b0035","unstructured":"Organization, W.H., Guidance on how to access the oral cholera vaccine (OCV) from the ICG emergency stockpile. Geneva, Switzerland: World Health Organization, 2013."},{"key":"10.1016\/j.vaccine.2019.06.082_b0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijid.2016.02.890","article-title":"Clinical review of Shanchol\u2122(a WHO pre-qualified oral cholera vaccine)","volume":"45","author":"D\u2019Cor","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.082_b0045","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"10001","key":"10.1016\/j.vaccine.2019.06.082_b0050","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"Lancet"},{"issue":"49","key":"10.1016\/j.vaccine.2019.06.082_b0055","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2019.06.082_b0060","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.082_b0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.082_b0070","doi-asserted-by":"crossref","first-page":"e0003809","DOI":"10.1371\/journal.pntd.0003809","article-title":"An open label non-inferiority trial assessing vibriocidal response of a killed bivalent oral cholera vaccine regimen following a five year interval in Kolkata, India","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.06.082_b0075","unstructured":"Organization, W.H., Cholera vaccines: WHO position paper\u2013August 2017. Weekly Epidemiological Record, 2017. 92(34): p. 477\u2013498."},{"issue":"13","key":"10.1016\/j.vaccine.2019.06.082_b0080","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.vaccine.2016.02.020","article-title":"The oral cholera vaccine Shanchol\u2122 when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants","volume":"34","author":"Saha","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.082_b0085","doi-asserted-by":"crossref","first-page":"e0003574","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing\u2014a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.082_b0090","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2017.01.080","article-title":"Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh","volume":"35","author":"Khan","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.06.082_b0095","doi-asserted-by":"crossref","first-page":"e0183100","DOI":"10.1371\/journal.pone.0183100","article-title":"Identification of burden hotspots and risk factors for cholera in India: an observational study","volume":"12","author":"Ali","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.082_b0100","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"suppl_3","key":"10.1016\/j.vaccine.2019.06.082_b0105","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","article-title":"Global cholera epidemiology: opportunities to reduce the burden of cholera by 2030","volume":"218","author":"Legros","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.082_b0110","series-title":"No end to cholera without basic water, sanitation and hygiene","first-page":"371","author":"Montgomery","year":"2018"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.082_b0115","doi-asserted-by":"crossref","first-page":"e0006369","DOI":"10.1371\/journal.pntd.0006369","article-title":"Highly targeted cholera vaccination campaigns in urban setting are feasible: the experience in Kalemie, Democratic Republic of Congo","volume":"12","author":"Massing","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.082_b0120","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/S2214-109X(15)70015-X","article-title":"Effectiveness of oral cholera vaccine in Haiti","volume":"3","author":"Luquero","year":"2015","journal-title":"Lancet Global Health"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.082_b0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:12Z","timestamp":1759401492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19308709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":25,"alternative-id":["S0264410X19308709"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}